Closed Health
PredictTB

Using Biomarkers to Predict TB Treatment Duration

€7.7MFunding
60Months
8Partners

Fact sheet

Programme
Horizon 2020 & sub-programmes
Companies
EURICE
Duration
60 months (February 2017 – January 2022)
Project funding
€ 7,722,491.00
Project partners
8
Project website
http://predict-tb.com

About the project

Shortening the duration of treatment for patients with drug sensitive tuberculosis from 6 to 4 months has been attempted many times in clinical trials but thus far all have failed. These failures reveal the incomplete understanding of factors driving the need for such extensive treatments. The objective of PredictTB is to identify those patients who are cured at 16 weeks, successfully accomplishing treatment shortening even with present drugs.

Coordinator

Prof Gerhard Walzl
Stellenbosch University
Phone: +27 21 938 9158
Email coordinator